In the United States, TB has re-emerged as a serious public health problem. In addition to those with active TB, an estimated 10 to 15 million people in the United States are infected with M. Tuberculosis without displaying symptoms (latent TB) and about one in ten of these individuals will develop active TB at some time in their lives. Minorities are affected disproportionately by TB: 54 percent of active TB cases in 1999 were among African-American and Hispanic people, with an additional 20 percent found in Asians. This issue updates the reader on the diagnosis and treatment of tuberculosis.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Elsevier - Health Sciences Division
Zielgruppe
Illustrationen
ISBN-13
978-1-4160-2811-6 (9781416028116)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
1. New Diagnostic Tools for Latent Tuberculosis and Active Disease (Schluger) 2. Tuberculosis Vaccines: Past, Present and Future (Geiter) 3. Genetic Susceptibility to Tuberculosis (Bellamy) 4. Epidemiology of Tuberculosis in the United States (Castro and Schneider) 5. Treatment of Latent Tuberculosis Infection (Sterling) 6. Global Epidemiology of TB (Raviglione and Maher) 7. The DOTS Strategy for Controlling the Global TB Epidemic (Frieden) 8. The Origin and Evolution of M. Tuberculosis (Behr) 9. Public/NGO/Private Partnership in TB Research and Disease Control (Pablos-Mendez) 10. TB and HIV (Burman) 11. Tuberculosis in Children (Saiman and Feja) 12. Molecular Epidemiology: A Tool for Understanding and Control of Tuberculosis Transmission (Daley) 13. New Drugs for Tuberculosis (O'Brien and Spigelman) 14. Treatment of Active Tuberculosis (Weis)
